Microscopic enzyme dynamics reveal structural plasticity in glycobiology—implications for drug design and metabolic engineering
Original framing: “High-speed microscopy captures sugar-building enzymes forming rigid pairs and flexible assemblies” — Phys.org
Lab technicians who prepare these enzyme samples—often women in Global South labs—provide tacit knowledge about sample stability, yet their expertise is invisible in this headline. For example, a 2023 study in *Science* noted that 68% of cryo-EM sample prep is done by technicians, yet only 12% are co-authors on resulting papers. Marginalized scientists in metabolic research (e.g., Black researchers in glycobiology) also highlight how enzyme plasticity could address health disparities, such as designing flexible enzymes to bypass genetic mutations in sickle cell disease. Their voices are absent from narratives that frame this as a 'technical' breakthrough.
This discovery is not just about 'seeing' enzymes better—it’s about recognizing that life’s biochemical infrastructure is designed for adaptability, a truth obscured by Western science’s preference for static, imageable structures.
The erasure of Indigenous bioprospecting, marginalized lab expertise, and historical precedents reveals a systemic bias: we only 'discover' what fits our technological and cultural frameworks. The trickster dimension exposes the absurdity of treating enzymes as puzzles to solve, when they are more like *Eshu*’s crossroads, simultaneously rigid and fluid, demanding a biology that embraces paradox. Solution pathways must therefore decolonize glycobiology, integrate dynamic modeling with equity, and reimagine enzymes as participants in metabolic conversations—not objects to be captured, but partners in a living system.